Skip to content

Evaluation of the effect of formulation Arctium Lappa in the treatment of Mild-to-moderate Acne

Evaluation of the effect of topical formulation prepared from hydroalcoholic extract of Arctium Lappa's root in the treatment of mild and moderate Acne Vulgaris

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191111045408N1
Enrollment
100
Registered
2019-11-24
Start date
2020-04-13
Completion date
Unknown
Last updated
2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

?Acne Vulgaris. Acne vulgaris (or simply acne) is a long-term skin disease that occurs when hair follicles become clogged with dead skin cells and oil from the skin. Acne is characterized by areas of blackheads, whiteheads, pimples, and greasy skin, and may result in sca

Interventions

Intervention 1: Intervention group: Topical tretinoin formulation and Arctium Lappa topical formulation are applied once daily for three months on face skin. Intervention 2: Control group: Topical app

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 30 Years

Inclusion criteria

Inclusion criteria: Women and men aged 12-30 years with mild to moderate acne vulgaris Have signed the informed consent form

Exclusion criteria

Exclusion criteria: Pregnant or breastfeeding or planning to become pregnant Have a history of sensitivity to the components of the formulations used in the study Other skin diseases such as eczema that make it difficult to evaluate the response to treatment Have uncontrolled systemic disease They have Acne Conglobata Not taking the following drugs before starting the plan (topical anti-acne drugs for two weeks, oral antibiotics for one month, 12 weeks hormone therapy and 6 months oral retinoids).

Design outcomes

Primary

MeasureTime frame
Acne Complication. Timepoint: One month after intervention, two months after intervention, three months after intervention. Method of measurement: Based on acne lesion counting.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmirreza Entezari

Mashhad University of Medical Sciences

entezariar941@mums.ac.ir+98 51 3180 1100

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026